Literature DB >> 6088263

Regulation of lysosomal autophagy in transformed and non-transformed mouse fibroblasts under several growth conditions.

E Knecht, J Hernández-Yago, S Grisolía.   

Abstract

The role of the lysosomal system in accelerated protein degradation was investigated in 3T3 mouse fibroblasts and in the SV40 virus-transformed derivative, SV3T3. Rates of protein degradation and quantitative electron microscopic alterations in the lysosomal system were compared under four different growing conditions: exponential growth, confluent phase, serum deprivation, and confluent phase together with serum deprivation. We found a significant correlation between increases in rates of proteolysis of long-lived proteins and fractional volume of lysosomes, suggesting a causal relationship between the two, as well as a morphological explanation for the differences in rates of protein degradation in transformed and non-transformed cultured cells. The increase in lysosomal fractional volume resulted from an increase in dense bodies only (in serum-deprived exponential or confluent cultures) or from an increase in autophagic vacuoles and dense bodies (in serum-supplemented confluent cultures).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088263     DOI: 10.1016/0014-4827(84)90682-7

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  14 in total

1.  Changes in the proteolytic activities of proteasomes and lysosomes in human fibroblasts produced by serum withdrawal, amino-acid deprivation and confluent conditions.

Authors:  Graciela Fuertes; José Javier Martín De Llano; Adoración Villarroya; A Jennifer Rivett; Erwin Knecht
Journal:  Biochem J       Date:  2003-10-01       Impact factor: 3.857

2.  Disruption of a Sirt1-dependent autophagy checkpoint in the prostate results in prostatic intraepithelial neoplasia lesion formation.

Authors:  Michael J Powell; Mathew C Casimiro; Carlos Cordon-Cardo; Xiaohong He; Wen-Shuz Yeow; Chenguang Wang; Peter A McCue; Michael W McBurney; Richard G Pestell
Journal:  Cancer Res       Date:  2010-12-28       Impact factor: 12.701

3.  Chaperone-mediated autophagy: Dice's 'wild' idea about lysosomal selectivity.

Authors:  Ana Maria Cuervo
Journal:  Nat Rev Mol Cell Biol       Date:  2011-07-13       Impact factor: 94.444

Review 4.  Autophagy and lysosomal proteolysis in the liver.

Authors:  B Grinde
Journal:  Experientia       Date:  1985-09-15

5.  Resveratrol-induced autophagy in human U373 glioma cells.

Authors:  Midori Yamamoto; Satoshi O Suzuki; Masaru Himeno
Journal:  Oncol Lett       Date:  2010-05-01       Impact factor: 2.967

6.  Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene.

Authors:  Xueping Qu; Jie Yu; Govind Bhagat; Norihiko Furuya; Hanina Hibshoosh; Andrea Troxel; Jeffrey Rosen; Eeva-Liisa Eskelinen; Noboru Mizushima; Yoshinori Ohsumi; Giorgio Cattoretti; Beth Levine
Journal:  J Clin Invest       Date:  2003-11-24       Impact factor: 14.808

7.  Vanadate inhibits degradation of short-lived, but not of long-lived, proteins in L-132 human cells.

Authors:  J L Vargas; F Aniento; J Cervera; E Knecht
Journal:  Biochem J       Date:  1989-02-15       Impact factor: 3.857

8.  Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.

Authors:  Olga V Leontieva; Zoya N Demidenko; Mikhail V Blagosklonny
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-02       Impact factor: 11.205

9.  Alterations in ROS activity and lysosomal pH account for distinct patterns of macroautophagy in LINCL and JNCL fibroblasts.

Authors:  José Manuel Vidal-Donet; Jaime Cárcel-Trullols; Bonaventura Casanova; Carmen Aguado; Erwin Knecht
Journal:  PLoS One       Date:  2013-02-07       Impact factor: 3.240

10.  PTEN increases autophagy and inhibits the ubiquitin-proteasome pathway in glioma cells independently of its lipid phosphatase activity.

Authors:  Rajaa Errafiy; Carmen Aguado; Ghita Ghislat; Juan M Esteve; Anabel Gil; Mohammed Loutfi; Erwin Knecht
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.